Profile

Cover photo
3,801 followers|1,011,219 views
AboutPostsPhotosYouTube

Stream

MAPS

Shared publicly  - 
 
+C-SPAN interviews archivist Stephanie Schmitz of +Purdue University's Psychoactive Substances Research Collection to discuss rare books and medical research from psychedelic research pioneers on the use of psychedelics as treatments for a variety of mental illnesses.
Archivist Stephanie Schmitz talks about Purdue University's Psychoactive Substances Research Collection. The collection includes rare books and medical research on the use of psychoactive substances…
3
Add a comment...

MAPS

Shared publicly  - 
 
MAPS 30th Anniversary Banquet and Celebration

At MAPS' 30th Anniversary Banquet and Celebration, the psychedelic science community will come together to celebrate the progress we've made since MAPS' founding in 1986. psychedelicdinners.org/banquet
3
1
prosody “Vereable” Context's profile photo
Add a comment...

MAPS

Shared publicly  - 
 
+reset.me reports on a new group at the +Yale School of Medicine, the Yale Psychiatry and Psychedelics Group (YPPG), highlighting MAPS as one of the leading organizations helping to promote and fund ongoing psychedelic research.
The slow advance of psychedelic-aided therapy into mainstream American consciousness is gaining gravitas, with Yale University joining the fray. Members of the Yale School of Medicine have formed the Yale Psychiatry and Psychedelics Group (YPSG) to discuss the growing body of research around the use of psychedelic substances in therapeutic settings.
4
1
Sheilah Shakti's profile photo
Add a comment...

MAPS

Shared publicly  - 
 
You're invited to join the Multidisciplinary Association for Psychedelic Studies (+MAPS) and the global psychedelic community for a benefit banquet and celebration on April 17, 2016, at the magnificent Scottish Rite Center in Oakland, California, celebrating three decades of advancements in psychedelic research and therapy. psychedelicdinners.org/banquet
1
1
Rick Doblin's profile photo
Add a comment...

MAPS

Shared publicly  - 
 
The +Washington Post reports on clinical research into ketamine showing promising results for treatment-resistant depression.
Ketamine, an anesthetic known as Special K, can work within hours.
5
3
clara mavridis's profile photoRick Doblin's profile photo
Add a comment...

MAPS

Shared publicly  - 
 
Ibogaine Therapy for Drug Addiction

MAPS is studying the long-term effects of ibogaine treatment on patients presently undergoing therapy at independent ibogaine treatment centers in Mexico and New Zealand. maps.org/ibogaine
6
2
Rick Doblin's profile photoSneha Ks's profile photo
Add a comment...

MAPS

Shared publicly  - 
 
Sign-up for the MAPS Email Newsletter

Subscribe to the MAPS Email Newsletter for research updates, event announcements, news, multimedia, and more from the fast-growing fields of psychedelic and medical marijuana science, therapy, and spirituality. maps.org/newsletter
9
1
Rick Doblin's profile photo
Add a comment...
Have them in circles
3,801 people
Chelsea Currey's profile photo
Ramsey Metcalf's profile photo
Billy Pillow's profile photo
behavenet's profile photo
Jenny Ugalde's profile photo
William Brodnos's profile photo
George Hayford-Taylor's profile photo
Bruce Edwards's profile photo
Sue Carden's profile photo

Communities

MAPS

Shared publicly  - 
 
After more than 20 years of research into the neurophysiology and toxicology of MDMA, this substance is now becoming subject of serious, well-controlled studies in a clinical population of subjects suffering from treatment-resistant posttraumatic stress disorder (PTSD).
7
1
gary lopez-watts's profile photoprosody “Vereable” Context's profile photo
 
lend your support in convincing those in power of the benefit of psychedelics and psychoactive substances in general. i know that this is what you are doing, i just want to stress that psychoactive substances in general are an easy means of entertainment, psychedelics of which play an introductory and explanatory role.
Add a comment...

MAPS

Shared publicly  - 
 
+The Huffington Post interviews psychedelic researcher Dr. Gabor Mate to discuss the potential of ayahuasca and other psychedelics for treating addiction, depression, and posttraumatic stress disorder (PTSD).
Understanding the root causes of addiction can help us to better treat it.
7
1
Tânia Morais's profile photo
Add a comment...

MAPS

Shared publicly  - 
 
Zendo Project: Psychedelic Harm Reduction

This year, millions of people will use psychedelics at festivals, concerts, and other events, many for the first time. Some of these psychedelic experiences will be difficult ones, sometimes called “bad trips.” However, difficult psychedelic experiences are not necessarily bad, but rather—with support and a safe space—they can be valuable opportunities for personal growth and transformation. http://bit.ly/1SLGsLy
3
2
Zendo Project's profile photoprosody “Vereable” Context's profile photo
Add a comment...

MAPS

Shared publicly  - 
 
For the entire month of April 2016, the Multidisciplinary Association for Psychedelic Studies (+MAPS) invites you to gather your friends, family, and colleagues for your own Global Psychedelic Dinner. You'll join a worldwide community of people participating—in person and online—in the global movement to make psychedelic therapy a legal treatment. psychedelicdinners.org
11
3
Jason Bunting's profile photoRick Doblin's profile photoprosody context (yo)'s profile photoprosody “Vereable” Context's profile photo
2 comments
 
+Jason Bunting Great idea. (Better because it has the word eat in it ;)) And maybe I'm not cool as u, but I will still go to a psychadelic dinner with ne of you. <3
Add a comment...

MAPS

Shared publicly  - 
 
Therapy with Substance is a comprehensive guide for the medical use of psychedelic substances in the therapy of emotional and psychosomatic disorders. http://bit.ly/20CPPjl
6
Add a comment...
Story
Tagline
Supporting psychedelic and medical marijuana research since 1986
Introduction
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization. MAPS functions as a non-profit pharmaceutical company working to make psychedelics and medical marijuana available to patients, physicians, and therapists on a legal, prescription, generic basis for public health benefits and health care cost savings.
Contact Information
Contact info
Phone
831-429-MDMA (6362)